US Court of Appeals upholds Novartis Entresto patent (NVS:NYSE)

Novartis (NYSE:NVS) said the U.S. Court of Appeals for the Federal Circuit has upheld the company’s U.S. combination patent for its blockbuster cardiac drug Entresto, also known as sacubitril/valsartan.

The Swiss drugmaker said it will work to enforce the patent